Peripheral Vascular Disease Imaging 

  • Author: Vibhuti N Singh, MD, MPH, FACC, FSCAI; Chief Editor: Kyung J Cho, MD, FACR   more...
 
Updated: Oct 21, 2011
 

Overview

Peripheral vascular disease (PVD), or atherosclerosis of peripheral vessels, is the most common cause of symptomatic stenosis in the human vascular tree. The pathogenetic mechanisms that lead to PVD are similar to those of coronary artery disease (CAD). The risk factors are also similar and include a positive family history, cigarette smoking, diabetes, hypertension, dyslipidemia, advanced age, and physical inactivity, among others. Angiograms demonstrating PVD appear below.[1, 2]

Bilateral aortoiliac stenosis. Bilateral aortoiliac stenosis. Superficial femoral artery stenosis causing claudiSuperficial femoral artery stenosis causing claudication. Left subclavian artery stenosis. Left subclavian artery stenosis. Left renal artery stenosis. Left renal artery stenosis.

Percutaneous revascularization with techniques such as percutaneous transluminal angioplasty (PTA), a less invasive option in the management of peripheral vascular disease (PVD), has been furthered by the work of pioneers such as Dotter and Gruntzig.[3] Over the past 30 years, there has been steady growth in the use of PTA, and it has become the first-line therapy for PVD (see the images below).[4, 5, 6]

Percutaneous transluminal angioplasty of superficiPercutaneous transluminal angioplasty of superficial femoral artery stenosis, performed with a long balloon via a contralateral femoral approach. Angiogram obtained after percutaneous transluminalAngiogram obtained after percutaneous transluminal angiography for superficial femoral artery stenosis.

This article will discuss diagnostic imaging techniques used in PVD.

Patient education

For patient information resources, see the Circulatory Problems Center and Cholesterol Center, as well as Peripheral Vascular Disease, High Cholesterol, and Cholesterol FAQs.

Next

Iliofemoral Disease

Noninvasive and invasive modalities are used for diagnostic evaluation in iliofemoral disease. Noninvasive testing includes Doppler ultrasonography and magnetic resonance angiography (MRA).[7]

Doppler ultrasonography and evaluation of the ankle-brachial index

For Doppler ultrasonography, pneumatic cuffs are placed along the leg and are inflated to suprasystolic pressures. During controlled cuff deflation, a Doppler probe is placed over the dorsalis pedis artery or posterior tibial artery to detect the onset of flow. Normally, the systolic blood pressure in the leg is slightly higher than that in the arm; therefore, the normal ankle-brachial index (ABI) of systolic blood pressure should be 1.0 or slightly greater. An ABI of less than 0.95 is considered abnormal. Patients with leg claudication typically have an ABI of less than 0.8. In patients with ischemia at rest, the ABI is frequently less than 0.4.

Magnetic resonance angiography

MRA is another noninvasive approach for imaging the peripheral circulation. It does not involve the risk of intravascular catheterization or conventional contrast agents.[8]

Angiography

Invasive imaging with contrast arteriography is required when the diagnosis remains unclear or endovascular procedures are planned (see the images below).

Superficial femoral artery stenosis causing claudiSuperficial femoral artery stenosis causing claudication. Preangioplasty left superficial femoral artery angPreangioplasty left superficial femoral artery angiogram in a middle-aged woman with severe left leg claudication and an ankle-brachial index of 0.5 on preadmission noninvasive assessment was recorded via a contralateral approach after sterile prepping and draping of the patient, administration of conscious sedation, the infiltration of local anesthetic (usually lidocaine 1% or 2% solution) at the right femoral access site, placement of an arterial sheath in the femoral artery, and advancement of the contra guide catheter over 0.035-in guidewire under fluoroscopic guidance. The tip of the guide catheter is taken beyond the aortobifemoral junction and positioned into the right iliac artery. An angiogram (as shown) is obtained after the guidewire is removed. The proximal end of the catheter is connected to a manifold and 4-8 mL of contrast agent is manually injected during cineangiographic recording. The image may be played in a loop, or a particular frame may be saved for use as a roadmap during angioplasty. Intravenous antithrombin agent, usually heparin, is administered as a bolus (generally 3000-4000 IU) before angioplasty. The patient's activated clotting time is monitored, with continuous monitoring of intra-arterial pressure, pulse oximetry, and heart rate.

Although digital subtraction angiography is the gold standard, duplex ultrasound has shown good accuracy in the detection of femoropopliteal lesions. Khan et al proposed 200 cm/s peak systolic velocity and a 2.0 velocity ratio to discern between < 70% and ≥ 70% stenosis in the femoropopliteal arterial segment.[9]

Previous
Next

Renal Artery Stenoses

Atherosclerotic disease that causes stenosis of more than 50% in at least 1 renal artery is encountered in 30% of patients with CAD, 38% of patients with abdominal aortic aneurysms (AAAs), and 39% of patients with iliofemoral disease (see the image below). In approximately one third of cases, renal artery disease is bilateral. About 11% of renal arteries with stenoses of greater than 60% progress to total occlusion within 2 years.[10, 11]

Left renal artery stenosis. Left renal artery stenosis.

In the past, captopril renography was used in the diagnosis of bilateral renal artery stenosis. The possibility of the development of renal atherosclerosis may be assessed just as accurately on the basis of clinical parameters, such as advanced age; female sex; the presence of atherosclerosis in other vascular beds; the recent onset of hypertension; smoking; the presence of abdominal bruits; an elevation in the creatinine level; and hypercholesterolemia. MRA has emerged as a potentially useful noninvasive imaging method for diagnosing renal artery stenosis.

Flush abdominal aortography in patients undergoing coronary arteriography may be performed when the likelihood of renovascular disease is high. This imaging is usually performed by placing a pigtail catheter at the level of the first lumbar vertebra and injecting contrast material at a rate of 20 mL/s to achieve a total contrast-agent volume of 6-12 mL.

Previous
Next

Subclavian, Brachiocephalic, and Carotid Artery Disease

Subclavian and brachiocephalic artery disease

Patients with atherosclerotic disease of an upper extremity may develop symptoms of ischemia, but these occur less commonly than do symptoms of iliofemoral disease. Most patients with atherosclerotic obstruction of the subclavian or brachiocephalic arteries are asymptomatic. Usually, the condition is incidentally discovered when there is a difference between blood pressure measurements of a patient's arms or when evidence of obstructive disease is observed during angiography or during a noninvasive evaluation. An angiogram of subclavian artery stenosis appears below.

Left subclavian artery stenosis. Left subclavian artery stenosis.

Carotid artery disease

The types of stroke include ischemic stroke, cardioembolic stroke, and others.

A diagnosis of carotid artery disease by means of physical examination alone is probably inaccurate. The anatomic diagnosis of carotid disease may be confirmed through noninvasive or invasive angiographic approaches (see the image below). Some authors advocate the use of duplex and transcranial Doppler ultrasonography as the first step in the evaluation of carotid disease; this approach is accurate in 90% of cases.

Left carotid artery stenosis. Left carotid artery stenosis.

MRA is emerging as a noninvasive means of visualizing the carotid, vertebrobasilar, and major intracranial vessels, but it provides less detail than do contrast-enhanced modalities. When the combination of MRA and Doppler ultrasonography is used, however, nearly 100% specificity in defining the hemodynamic severity of carotid stenoses is achieved.

Previous
Next

Abdominal Aortic Aneurysm

Although aneurysms may affect any arterial bed, infrarenal abdominal aortic aneurysms (AAAs) account for most arterial aneurysms. An AAA is defined as an aneurysm having a diameter of greater than 3 cm. Most AAAs are incidentally discovered during abdominal ultrasonography or angiographic examinations performed for other indications.

The growth rate for AAAs is variable; the average growth rate is 0.3-0.5 cm per year. Whether or not an aneurysm ruptures is most strongly related to its size.

Accurate sizing requires the performance of abdominal ultrasonography, computed tomography (CT) scanning, or magnetic resonance imaging (MRI). Aortography is not a reliable means of determining the size of the aneurysm, because a laminated thrombus, if present, may cause the size of the aneurysm to be underestimated.

Previous
 
Contributor Information and Disclosures
Author

Vibhuti N Singh, MD, MPH, FACC, FSCAI  Director, Suncoast Cardiovascular Center; Chair, Cardiology Division and Cath Labs, Department of Medicine, Bayfront Medical Center; Clinical Assistant Professor, Division of Cardiology, University of South Florida College of Medicine

Vibhuti N Singh, MD, MPH, FACC, FSCAI is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Heart Association, American Medical Association, and Florida Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Anthony Watkinson, MD  Professor of Interventional Radiology, The Peninsula Medical School; Consultant and Senior Lecturer, Department of Radiology, The Royal Devon and Exeter Hospital, UK

Anthony Watkinson, MD is a member of the following medical societies: Radiological Society of North America, Royal College of Radiologists, and Royal College of Surgeons of England

Disclosure: Nothing to disclose.

Bernard D Coombs, MB, ChB, PhD  Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand

Disclosure: Nothing to disclose.

Douglas M Coldwell, MD, PhD  Professor of Radiology, Director, Division of Vascular and Interventional Radiology, University of Louisville School of Medicine

Douglas M Coldwell, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American College of Radiology, American Heart Association, American Physical Society, American Roentgen Ray Society, Society of Cardiovascular and Interventional Radiology, Southwest Oncology Group, and Special Operations Medical Association

Disclosure: Sirtex, Inc. Consulting fee Speaking and teaching

Robert M Krasny, MD  Resolution Imaging Medical Corporation

Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America

Disclosure: Nothing to disclose.

Chief Editor

Kyung J Cho, MD, FACR  William Martel Professor of Radiology, Interventional Radiology Fellowship Director, University of Michigan Health System

Kyung J Cho, MD, FACR is a member of the following medical societies: American College of Radiology, American Heart Association, American Medical Association, American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors would like to acknowledge Alan Cousin, MD, for his contributions to this topic.

References
  1. Halperin JL. Evaluation of patients with peripheral vascular disease. Thromb Res. 2002;106(6):V303-11. [Medline].

  2. Bueno A, Acín F, Canibano C, et al. Diagnostic accuracy of contrast-enhanced magnetic resonance angiography and duplex ultrasound in patients with peripheral vascular disease. Vasc Endovascular Surg. Oct 2010;44(7):576-85. [Medline].

  3. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. 1964. Radiology. Sep 1989;172(3 Pt 2):904-20. [Medline].

  4. Wholey MH, Barbato JE, Al-Khoury GE. Treatment of asymptomatic carotid disease with stenting: pro. Semin Vasc Surg. Jun 2008;21(2):95-9. [Medline].

  5. Mathur A, Roubin GS, Iyer SS, Piamsonboon C, Liu MW, Gomez CR, et al. Predictors of stroke complicating carotid artery stenting. Circulation. Apr 7 1998;97(13):1239-45. [Medline].

  6. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology. Jul 2008;248(1):297-302. [Medline].

  7. Shareghi S, Gopal A, Gul K, et al. Diagnostic accuracy of 64 multidetector computed tomographic angiography in peripheral vascular disease. Catheter Cardiovasc Interv. Jan 1 2010;75(1):23-31. [Medline].

  8. Mohrs OK, Petersen SE, Heidt MC, et al. High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: Comparison with contrast-enhanced MR angiography. Eur Radiol. Feb 2011;21(2):434-42. [Medline].

  9. Khan SZ, Khan MA, Bradley B, Dayal R, McKinsey JF, Morrissey NJ. Utility of duplex ultrasound in detecting and grading de novo femoropopliteal lesions. J Vasc Surg. Oct 2011;54(4):1067-73. [Medline].

  10. Pillay WR, Kan YM, Crinnion JN. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Br J Surg. 2002;89(6):737-40. [Medline].

  11. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med. May 1 1993;118(9):712-9. [Medline].

Previous
Next
 
Bilateral aortoiliac stenosis.
Superficial femoral artery stenosis causing claudication.
Percutaneous transluminal angioplasty of superficial femoral artery stenosis, performed with a long balloon via a contralateral femoral approach.
Angiogram obtained after percutaneous transluminal angiography for superficial femoral artery stenosis.
Left subclavian artery stenosis.
Left carotid artery stenosis.
Left renal artery stenosis.
Preangioplasty right iliac angiogram in a middle-aged man with severe right leg claudication and an ankle-brachial index of 0.4 on preadmission, noninvasive assessment. The patient underwent sterile prepping and draping, conscious sedation was provided, infiltrating local anesthetic (usually lidocaine 1% or 2% solution) was administered at the femoral access site, an arterial sheath was placed in the femoral artery, and the guide catheter was advanced over 0.035-in guidewire under fluoroscopic guidance. Once the tip of the guide catheter is taken beyond the aortobifemoral junction and positioned into the right iliac artery, an angiogram (as shown) is obtained. After the guidewire is removed, the proximal end of the catheter is connected to a manifold, and 4-8 mL of contrast agent is manually injected during cineangiographic recording. The image may be played in a loop, or a particular frame may be saved for review during angioplasty. An intravenous antithrombotic agent, usually heparin, is administered before angioplasty. The patient's activated clotting time is monitored, with continuous monitoring of intra-arterial pressure, pulse oximetry, and heart rate.
After an initial diagnostic angiogram is obtained for use as a roadmap, a 0.018-in guidewire is introduced into the side opening of a Y-connector (attached to the manifold at 1 end and the proximal end of the guide catheter at the other). A small torque device is used over the proximal end of the guidewire for steering purposes, while a small terminal bend is created by hand over the distal end before the guidewire is introduced into the guide catheter. The wire is advanced through the 6F contra guide across the midright iliac stenosis. The passage of the guidewire is monitored with fluoroscopy and by injecting small amounts of contrast agent. Occasionally, a combination of torque and forward pressure is required to cross the lesion. In tight lesions, the balloon catheter is sometimes advanced as well and used as support for guidewire passage.A peripheral angioplasty balloon is prepared by connecting its proximal port to an inflating device that contains a half-and-half imaging contrast agent and sterile saline solution. Negative pressure is applied to extrude any air bubbles. The inflating device is left in negative pressure during advancement of the balloon with 1 hand over the guidewire, which is held with the other hand. The balloon is advanced beyond the distal end of the guide catheter and straddled across the stenosed segment. A small amount of contrast agent is injected to confirm proper positioning of the balloon.The balloon is inflated by dialing up the pressure with the inflation device to several atmospheres, usually 4-8 bars. The mixed contrast agent/saline solution contained in the inflation device moves gradually into the balloon due to the increasing pressure and, as the balloon expands, it becomes visible under fluoroscopy (as shown). The balloon is left in the inflated position for several seconds to exert circumferential pressure on the stenosed arterial segment and expand the luminal dimension. The balloon is deflated by drawing negative pressure through the inflation device. Once deflated, it is gradually pulled back into the guide catheter while the wire is retained across the lesion.
Angiogram obtained after percutaneous transluminal angioplasty shows increased luminal diameter at the stenotic segment, but it still appears to be narrow by at least 60%. There is moderate dissection, and the flow into the distal iliac artery is somewhat slow, but no filling defect (which may represent clot) is present. To patch the dissection, a self-expanding stent-balloon catheter is prepared in a manner similar to that used for a balloon catheter; however, before its insertion into the guide catheter, no negative pressure is applied. The stent catheter is advanced over the guidewire through the guide catheter beyond its distal end and taken across the lesion. The stent is positioned over the dissection by ascertaining its position by injecting a small amount of contrast material through the guide. The stent is deployed by pulling the overlying sleeve while the self-expanding stent gradually opens, beginning at the distal end. Every effort is made not to let the catheter move. The sleeve may always be advanced as long as it does not come back beyond the proximal end of the stent if repositioning becomes necessary. The sleeve and stent-balloon catheter are withdrawn, and the guidewire remains in place across the lesion.
Poststenting angiogram made following withdrawal of the guidewire. The guidewire is withdrawn after it is confirmed that no flap, dissection, or filling defect is present. The angiogram shows that the residual stenosis in the iliac artery is 0%. The guide catheter is finally withdrawn. The left femoral access site that provided a contralateral approach to the right iliac stenosis is closed with a percutaneous closure device.
Preangioplasty left superficial femoral artery angiogram in a middle-aged woman with severe left leg claudication and an ankle-brachial index of 0.5 on preadmission noninvasive assessment was recorded via a contralateral approach after sterile prepping and draping of the patient, administration of conscious sedation, the infiltration of local anesthetic (usually lidocaine 1% or 2% solution) at the right femoral access site, placement of an arterial sheath in the femoral artery, and advancement of the contra guide catheter over 0.035-in guidewire under fluoroscopic guidance. The tip of the guide catheter is taken beyond the aortobifemoral junction and positioned into the right iliac artery. An angiogram (as shown) is obtained after the guidewire is removed. The proximal end of the catheter is connected to a manifold and 4-8 mL of contrast agent is manually injected during cineangiographic recording. The image may be played in a loop, or a particular frame may be saved for use as a roadmap during angioplasty. Intravenous antithrombin agent, usually heparin, is administered as a bolus (generally 3000-4000 IU) before angioplasty. The patient's activated clotting time is monitored, with continuous monitoring of intra-arterial pressure, pulse oximetry, and heart rate.
Once the initial diagnostic angiogram is obtained for use as a roadmap, a 0.018-in guidewire is introduced into the side opening of a Y-connector (attached to the manifold at one end and the proximal end of the guide catheter at the other). A small torque device is used over the proximal end of the guidewire for steering purposes, while a small terminal bend is created by hand over the distal end of the guidewire before introducing it into the guide catheter. The wire is advanced through the 6F contra guide across the stenosis in the proximal segment of the left superficial femoral artery. The passage of the guidewire is monitored with fluoroscopy and by injecting small amounts of contrast agent. Occasionally, a combination of torque and forward pressure is required to cross the lesion. In tight lesions, the balloon catheter is sometimes advanced as well and used as support for guidewire passage.An angioplasty balloon is prepared by connecting its proximal port to an inflating device that contains a half-and-half imaging contrast agent and sterile saline solution. Negative pressure is applied to extrude any air bubbles. The inflating device is left in negative pressure during advancement of the balloon with one hand over the guidewire, which is held with the other hand. The balloon is advanced beyond the distal end of the guide catheter and straddled across the stenosed segment. A small amount of contrast agent is injected in order to confirm proper positioning of the balloon. The balloon is inflated by dialing up the pressure with the inflation device to several atmospheres (bars), usually 4-8 bars. The mixed contrast and saline solution contained in the inflation device moves gradually into the balloon as a result of the increasing pressure; as the balloon expands, it becomes visible under fluoroscopy (as shown). The balloon is left in the inflated position for several seconds to exert circumferential pressure on the stenosed arterial segment and expand the luminal dimension. The balloon is deflated by drawing negative pressure through the inflation device. Once deflated, it is gradually pulled back into the guide catheter while the wire is retained across the lesion.
Angiogram obtained after percutaneous transluminal angioplasty of the left superficial femoral artery (SFA) shows improvement in the luminal diameter at the stenosed segment; however, it still appears to be at least 70% narrowed, with linear dissection. To patch the dissection, a stent-balloon catheter is prepared similar to the balloon catheter, except that, prior to insertion into the guide catheter, no negative pressure is applied. The stent catheter is then advanced over the guidewire through the guide catheter beyond its distal end and taken across the lesion. The stent is positioned over the dissection by injecting a small amount of contrast material through the guide to confirm its proper positioning and cover the entire dissected segment. The stent is deployed by first drawing negative pressure in the stent balloon and, subsequently, inflating it by injecting the contrast-saline solution through the inflation device. The stent is left inflated for several seconds at 5-10 bars of pressure. The stent-balloon is then deflated and withdrawn, while retaining the guidewire across the lesion. A poststenting angiogram is obtained.
Poststenting angiogram obtained after withdrawal of the guidewire, which is done after confirming the absence of any flap, dissection, or filling defect. Image shows residual stenosis in the left superficial femoral artery (SFA) to be 0%. The guide catheter is finally withdrawn. The right femoral access site that provided contralateral approach to the left SFA stenosis is sealed with a percutaneous closure device.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.